Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients

Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients

BackgroundThe efficacy or tolerability of paliperidone extended release (ER) in the treatment of methamphetamine (METH)-associated psychosis (MAP) is unknown. This study was designed to assess the tolerability and efficacy of paliperidone ER and risperidone for the treatment of MAP in China.MethodsT...

Full description

Bibliographic Details
Main Authors: Gang Wang, Fan Ding, Marek Cezary Chawarski, Wei Hao, Xuebing Liu, Qijian Deng, Xuan Ouyang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Psychiatry
Subjects:
methamphetamine
psychosis
paliperidone extended-release
risperidone
efficacy
safety
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00237/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2020.00237/full

Similar Items